Global Human Rabies Vaccine (Vero Cell) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 106

Published Date: 21 Jan 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Human Rabies Vaccine (Vero Cell) market size was valued at USD 407.5 million in 2023 and is forecast to a readjusted size of USD 565.2 million by 2030 with a CAGR of 4.8% during review period.

Rabies is an acute infectious disease caused by rabies virus. There is no effective treatment for rabies clinically. Rabies vaccination after exposure can stimulate the body to produce immunity against rabies virus and prevent rabies.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Human Rabies Vaccine (Vero Cell) industry chain, the market status of Hospital (0.5ml, 1ml), Clinic (0.5ml, 1ml), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Human Rabies Vaccine (Vero Cell).

Regionally, the report analyzes the Human Rabies Vaccine (Vero Cell) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Human Rabies Vaccine (Vero Cell) market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Human Rabies Vaccine (Vero Cell) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Human Rabies Vaccine (Vero Cell) industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., 0.5ml, 1ml).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Human Rabies Vaccine (Vero Cell) market.

Regional Analysis: The report involves examining the Human Rabies Vaccine (Vero Cell) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Human Rabies Vaccine (Vero Cell) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Human Rabies Vaccine (Vero Cell):
Company Analysis: Report covers individual Human Rabies Vaccine (Vero Cell) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Human Rabies Vaccine (Vero Cell) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).

Technology Analysis: Report covers specific technologies relevant to Human Rabies Vaccine (Vero Cell). It assesses the current state, advancements, and potential future developments in Human Rabies Vaccine (Vero Cell) areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Human Rabies Vaccine (Vero Cell) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Human Rabies Vaccine (Vero Cell) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
0.5ml
1ml

Market segment by Application
Hospital
Clinic

Major players covered
Liaoning Chengda
Guangzhou Nuocheng
Ningbo Rong'an
Hualan Bio-vaccine
Sanofi Pasteur SA
Bharat Biotech
Bavarian Nordic
Serum Institute of India Pvt.
Chengdu Kanghua Biology
Changchun Zhuoyi Biology
Dalian Yali Peak
Jilin Huikang Biopharmaceutical Co., Ltd.

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Rabies Vaccine (Vero Cell) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Rabies Vaccine (Vero Cell), with price, sales, revenue and global market share of Human Rabies Vaccine (Vero Cell) from 2019 to 2024.
Chapter 3, the Human Rabies Vaccine (Vero Cell) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Rabies Vaccine (Vero Cell) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Human Rabies Vaccine (Vero Cell) market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Rabies Vaccine (Vero Cell).
Chapter 14 and 15, to describe Human Rabies Vaccine (Vero Cell) sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Human Rabies Vaccine (Vero Cell)
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Human Rabies Vaccine (Vero Cell) Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 0.5ml
        1.3.3 1ml
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Human Rabies Vaccine (Vero Cell) Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospital
        1.4.3 Clinic
    1.5 Global Human Rabies Vaccine (Vero Cell) Market Size & Forecast
        1.5.1 Global Human Rabies Vaccine (Vero Cell) Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Human Rabies Vaccine (Vero Cell) Sales Quantity (2019-2030)
        1.5.3 Global Human Rabies Vaccine (Vero Cell) Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Liaoning Chengda
        2.1.1 Liaoning Chengda Details
        2.1.2 Liaoning Chengda Major Business
        2.1.3 Liaoning Chengda Human Rabies Vaccine (Vero Cell) Product and Services
        2.1.4 Liaoning Chengda Human Rabies Vaccine (Vero Cell) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Liaoning Chengda Recent Developments/Updates
    2.2 Guangzhou Nuocheng
        2.2.1 Guangzhou Nuocheng Details
        2.2.2 Guangzhou Nuocheng Major Business
        2.2.3 Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Product and Services
        2.2.4 Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Guangzhou Nuocheng Recent Developments/Updates
    2.3 Ningbo Rong'an
        2.3.1 Ningbo Rong'an Details
        2.3.2 Ningbo Rong'an Major Business
        2.3.3 Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Product and Services
        2.3.4 Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Ningbo Rong'an Recent Developments/Updates
    2.4 Hualan Bio-vaccine
        2.4.1 Hualan Bio-vaccine Details
        2.4.2 Hualan Bio-vaccine Major Business
        2.4.3 Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Product and Services
        2.4.4 Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Hualan Bio-vaccine Recent Developments/Updates
    2.5 Sanofi Pasteur SA
        2.5.1 Sanofi Pasteur SA Details
        2.5.2 Sanofi Pasteur SA Major Business
        2.5.3 Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Product and Services
        2.5.4 Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Sanofi Pasteur SA Recent Developments/Updates
    2.6 Bharat Biotech
        2.6.1 Bharat Biotech Details
        2.6.2 Bharat Biotech Major Business
        2.6.3 Bharat Biotech Human Rabies Vaccine (Vero Cell) Product and Services
        2.6.4 Bharat Biotech Human Rabies Vaccine (Vero Cell) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Bharat Biotech Recent Developments/Updates
    2.7 Bavarian Nordic
        2.7.1 Bavarian Nordic Details
        2.7.2 Bavarian Nordic Major Business
        2.7.3 Bavarian Nordic Human Rabies Vaccine (Vero Cell) Product and Services
        2.7.4 Bavarian Nordic Human Rabies Vaccine (Vero Cell) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Bavarian Nordic Recent Developments/Updates
    2.8 Serum Institute of India Pvt.
        2.8.1 Serum Institute of India Pvt. Details
        2.8.2 Serum Institute of India Pvt. Major Business
        2.8.3 Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Product and Services
        2.8.4 Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Serum Institute of India Pvt. Recent Developments/Updates
    2.9 Chengdu Kanghua Biology
        2.9.1 Chengdu Kanghua Biology Details
        2.9.2 Chengdu Kanghua Biology Major Business
        2.9.3 Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Product and Services
        2.9.4 Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Chengdu Kanghua Biology Recent Developments/Updates
    2.10 Changchun Zhuoyi Biology
        2.10.1 Changchun Zhuoyi Biology Details
        2.10.2 Changchun Zhuoyi Biology Major Business
        2.10.3 Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Product and Services
        2.10.4 Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Changchun Zhuoyi Biology Recent Developments/Updates
    2.11 Dalian Yali Peak
        2.11.1 Dalian Yali Peak Details
        2.11.2 Dalian Yali Peak Major Business
        2.11.3 Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Product and Services
        2.11.4 Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Dalian Yali Peak Recent Developments/Updates
    2.12 Jilin Huikang Biopharmaceutical Co., Ltd.
        2.12.1 Jilin Huikang Biopharmaceutical Co., Ltd. Details
        2.12.2 Jilin Huikang Biopharmaceutical Co., Ltd. Major Business
        2.12.3 Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Product and Services
        2.12.4 Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Jilin Huikang Biopharmaceutical Co., Ltd. Recent Developments/Updates

3 Competitive Environment: Human Rabies Vaccine (Vero Cell) by Manufacturer
    3.1 Global Human Rabies Vaccine (Vero Cell) Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Human Rabies Vaccine (Vero Cell) Revenue by Manufacturer (2019-2024)
    3.3 Global Human Rabies Vaccine (Vero Cell) Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Human Rabies Vaccine (Vero Cell) by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Human Rabies Vaccine (Vero Cell) Manufacturer Market Share in 2023
        3.4.2 Top 6 Human Rabies Vaccine (Vero Cell) Manufacturer Market Share in 2023
    3.5 Human Rabies Vaccine (Vero Cell) Market: Overall Company Footprint Analysis
        3.5.1 Human Rabies Vaccine (Vero Cell) Market: Region Footprint
        3.5.2 Human Rabies Vaccine (Vero Cell) Market: Company Product Type Footprint
        3.5.3 Human Rabies Vaccine (Vero Cell) Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Human Rabies Vaccine (Vero Cell) Market Size by Region
        4.1.1 Global Human Rabies Vaccine (Vero Cell) Sales Quantity by Region (2019-2030)
        4.1.2 Global Human Rabies Vaccine (Vero Cell) Consumption Value by Region (2019-2030)
        4.1.3 Global Human Rabies Vaccine (Vero Cell) Average Price by Region (2019-2030)
    4.2 North America Human Rabies Vaccine (Vero Cell) Consumption Value (2019-2030)
    4.3 Europe Human Rabies Vaccine (Vero Cell) Consumption Value (2019-2030)
    4.4 Asia-Pacific Human Rabies Vaccine (Vero Cell) Consumption Value (2019-2030)
    4.5 South America Human Rabies Vaccine (Vero Cell) Consumption Value (2019-2030)
    4.6 Middle East and Africa Human Rabies Vaccine (Vero Cell) Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2019-2030)
    5.2 Global Human Rabies Vaccine (Vero Cell) Consumption Value by Type (2019-2030)
    5.3 Global Human Rabies Vaccine (Vero Cell) Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2019-2030)
    6.2 Global Human Rabies Vaccine (Vero Cell) Consumption Value by Application (2019-2030)
    6.3 Global Human Rabies Vaccine (Vero Cell) Average Price by Application (2019-2030)

7 North America
    7.1 North America Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2019-2030)
    7.2 North America Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2019-2030)
    7.3 North America Human Rabies Vaccine (Vero Cell) Market Size by Country
        7.3.1 North America Human Rabies Vaccine (Vero Cell) Sales Quantity by Country (2019-2030)
        7.3.2 North America Human Rabies Vaccine (Vero Cell) Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2019-2030)
    8.2 Europe Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2019-2030)
    8.3 Europe Human Rabies Vaccine (Vero Cell) Market Size by Country
        8.3.1 Europe Human Rabies Vaccine (Vero Cell) Sales Quantity by Country (2019-2030)
        8.3.2 Europe Human Rabies Vaccine (Vero Cell) Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Human Rabies Vaccine (Vero Cell) Market Size by Region
        9.3.1 Asia-Pacific Human Rabies Vaccine (Vero Cell) Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Human Rabies Vaccine (Vero Cell) Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2019-2030)
    10.2 South America Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2019-2030)
    10.3 South America Human Rabies Vaccine (Vero Cell) Market Size by Country
        10.3.1 South America Human Rabies Vaccine (Vero Cell) Sales Quantity by Country (2019-2030)
        10.3.2 South America Human Rabies Vaccine (Vero Cell) Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Human Rabies Vaccine (Vero Cell) Market Size by Country
        11.3.1 Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Human Rabies Vaccine (Vero Cell) Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Human Rabies Vaccine (Vero Cell) Market Drivers
    12.2 Human Rabies Vaccine (Vero Cell) Market Restraints
    12.3 Human Rabies Vaccine (Vero Cell) Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Human Rabies Vaccine (Vero Cell) and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Human Rabies Vaccine (Vero Cell)
    13.3 Human Rabies Vaccine (Vero Cell) Production Process
    13.4 Human Rabies Vaccine (Vero Cell) Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Human Rabies Vaccine (Vero Cell) Typical Distributors
    14.3 Human Rabies Vaccine (Vero Cell) Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Human Rabies Vaccine (Vero Cell) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Human Rabies Vaccine (Vero Cell) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Liaoning Chengda Basic Information, Manufacturing Base and Competitors
    Table 4. Liaoning Chengda Major Business
    Table 5. Liaoning Chengda Human Rabies Vaccine (Vero Cell) Product and Services
    Table 6. Liaoning Chengda Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Liaoning Chengda Recent Developments/Updates
    Table 8. Guangzhou Nuocheng Basic Information, Manufacturing Base and Competitors
    Table 9. Guangzhou Nuocheng Major Business
    Table 10. Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Product and Services
    Table 11. Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Guangzhou Nuocheng Recent Developments/Updates
    Table 13. Ningbo Rong'an Basic Information, Manufacturing Base and Competitors
    Table 14. Ningbo Rong'an Major Business
    Table 15. Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Product and Services
    Table 16. Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Ningbo Rong'an Recent Developments/Updates
    Table 18. Hualan Bio-vaccine Basic Information, Manufacturing Base and Competitors
    Table 19. Hualan Bio-vaccine Major Business
    Table 20. Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Product and Services
    Table 21. Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Hualan Bio-vaccine Recent Developments/Updates
    Table 23. Sanofi Pasteur SA Basic Information, Manufacturing Base and Competitors
    Table 24. Sanofi Pasteur SA Major Business
    Table 25. Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Product and Services
    Table 26. Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Sanofi Pasteur SA Recent Developments/Updates
    Table 28. Bharat Biotech Basic Information, Manufacturing Base and Competitors
    Table 29. Bharat Biotech Major Business
    Table 30. Bharat Biotech Human Rabies Vaccine (Vero Cell) Product and Services
    Table 31. Bharat Biotech Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Bharat Biotech Recent Developments/Updates
    Table 33. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
    Table 34. Bavarian Nordic Major Business
    Table 35. Bavarian Nordic Human Rabies Vaccine (Vero Cell) Product and Services
    Table 36. Bavarian Nordic Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. Bavarian Nordic Recent Developments/Updates
    Table 38. Serum Institute of India Pvt. Basic Information, Manufacturing Base and Competitors
    Table 39. Serum Institute of India Pvt. Major Business
    Table 40. Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Product and Services
    Table 41. Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. Serum Institute of India Pvt. Recent Developments/Updates
    Table 43. Chengdu Kanghua Biology Basic Information, Manufacturing Base and Competitors
    Table 44. Chengdu Kanghua Biology Major Business
    Table 45. Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Product and Services
    Table 46. Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 47. Chengdu Kanghua Biology Recent Developments/Updates
    Table 48. Changchun Zhuoyi Biology Basic Information, Manufacturing Base and Competitors
    Table 49. Changchun Zhuoyi Biology Major Business
    Table 50. Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Product and Services
    Table 51. Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 52. Changchun Zhuoyi Biology Recent Developments/Updates
    Table 53. Dalian Yali Peak Basic Information, Manufacturing Base and Competitors
    Table 54. Dalian Yali Peak Major Business
    Table 55. Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Product and Services
    Table 56. Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 57. Dalian Yali Peak Recent Developments/Updates
    Table 58. Jilin Huikang Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 59. Jilin Huikang Biopharmaceutical Co., Ltd. Major Business
    Table 60. Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Product and Services
    Table 61. Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 62. Jilin Huikang Biopharmaceutical Co., Ltd. Recent Developments/Updates
    Table 63. Global Human Rabies Vaccine (Vero Cell) Sales Quantity by Manufacturer (2019-2024) & (K Units)
    Table 64. Global Human Rabies Vaccine (Vero Cell) Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 65. Global Human Rabies Vaccine (Vero Cell) Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 66. Market Position of Manufacturers in Human Rabies Vaccine (Vero Cell), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 67. Head Office and Human Rabies Vaccine (Vero Cell) Production Site of Key Manufacturer
    Table 68. Human Rabies Vaccine (Vero Cell) Market: Company Product Type Footprint
    Table 69. Human Rabies Vaccine (Vero Cell) Market: Company Product Application Footprint
    Table 70. Human Rabies Vaccine (Vero Cell) New Market Entrants and Barriers to Market Entry
    Table 71. Human Rabies Vaccine (Vero Cell) Mergers, Acquisition, Agreements, and Collaborations
    Table 72. Global Human Rabies Vaccine (Vero Cell) Sales Quantity by Region (2019-2024) & (K Units)
    Table 73. Global Human Rabies Vaccine (Vero Cell) Sales Quantity by Region (2025-2030) & (K Units)
    Table 74. Global Human Rabies Vaccine (Vero Cell) Consumption Value by Region (2019-2024) & (USD Million)
    Table 75. Global Human Rabies Vaccine (Vero Cell) Consumption Value by Region (2025-2030) & (USD Million)
    Table 76. Global Human Rabies Vaccine (Vero Cell) Average Price by Region (2019-2024) & (US$/Unit)
    Table 77. Global Human Rabies Vaccine (Vero Cell) Average Price by Region (2025-2030) & (US$/Unit)
    Table 78. Global Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2019-2024) & (K Units)
    Table 79. Global Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2025-2030) & (K Units)
    Table 80. Global Human Rabies Vaccine (Vero Cell) Consumption Value by Type (2019-2024) & (USD Million)
    Table 81. Global Human Rabies Vaccine (Vero Cell) Consumption Value by Type (2025-2030) & (USD Million)
    Table 82. Global Human Rabies Vaccine (Vero Cell) Average Price by Type (2019-2024) & (US$/Unit)
    Table 83. Global Human Rabies Vaccine (Vero Cell) Average Price by Type (2025-2030) & (US$/Unit)
    Table 84. Global Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2019-2024) & (K Units)
    Table 85. Global Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2025-2030) & (K Units)
    Table 86. Global Human Rabies Vaccine (Vero Cell) Consumption Value by Application (2019-2024) & (USD Million)
    Table 87. Global Human Rabies Vaccine (Vero Cell) Consumption Value by Application (2025-2030) & (USD Million)
    Table 88. Global Human Rabies Vaccine (Vero Cell) Average Price by Application (2019-2024) & (US$/Unit)
    Table 89. Global Human Rabies Vaccine (Vero Cell) Average Price by Application (2025-2030) & (US$/Unit)
    Table 90. North America Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2019-2024) & (K Units)
    Table 91. North America Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2025-2030) & (K Units)
    Table 92. North America Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2019-2024) & (K Units)
    Table 93. North America Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2025-2030) & (K Units)
    Table 94. North America Human Rabies Vaccine (Vero Cell) Sales Quantity by Country (2019-2024) & (K Units)
    Table 95. North America Human Rabies Vaccine (Vero Cell) Sales Quantity by Country (2025-2030) & (K Units)
    Table 96. North America Human Rabies Vaccine (Vero Cell) Consumption Value by Country (2019-2024) & (USD Million)
    Table 97. North America Human Rabies Vaccine (Vero Cell) Consumption Value by Country (2025-2030) & (USD Million)
    Table 98. Europe Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2019-2024) & (K Units)
    Table 99. Europe Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2025-2030) & (K Units)
    Table 100. Europe Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2019-2024) & (K Units)
    Table 101. Europe Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2025-2030) & (K Units)
    Table 102. Europe Human Rabies Vaccine (Vero Cell) Sales Quantity by Country (2019-2024) & (K Units)
    Table 103. Europe Human Rabies Vaccine (Vero Cell) Sales Quantity by Country (2025-2030) & (K Units)
    Table 104. Europe Human Rabies Vaccine (Vero Cell) Consumption Value by Country (2019-2024) & (USD Million)
    Table 105. Europe Human Rabies Vaccine (Vero Cell) Consumption Value by Country (2025-2030) & (USD Million)
    Table 106. Asia-Pacific Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2019-2024) & (K Units)
    Table 107. Asia-Pacific Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2025-2030) & (K Units)
    Table 108. Asia-Pacific Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2019-2024) & (K Units)
    Table 109. Asia-Pacific Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2025-2030) & (K Units)
    Table 110. Asia-Pacific Human Rabies Vaccine (Vero Cell) Sales Quantity by Region (2019-2024) & (K Units)
    Table 111. Asia-Pacific Human Rabies Vaccine (Vero Cell) Sales Quantity by Region (2025-2030) & (K Units)
    Table 112. Asia-Pacific Human Rabies Vaccine (Vero Cell) Consumption Value by Region (2019-2024) & (USD Million)
    Table 113. Asia-Pacific Human Rabies Vaccine (Vero Cell) Consumption Value by Region (2025-2030) & (USD Million)
    Table 114. South America Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2019-2024) & (K Units)
    Table 115. South America Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2025-2030) & (K Units)
    Table 116. South America Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2019-2024) & (K Units)
    Table 117. South America Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2025-2030) & (K Units)
    Table 118. South America Human Rabies Vaccine (Vero Cell) Sales Quantity by Country (2019-2024) & (K Units)
    Table 119. South America Human Rabies Vaccine (Vero Cell) Sales Quantity by Country (2025-2030) & (K Units)
    Table 120. South America Human Rabies Vaccine (Vero Cell) Consumption Value by Country (2019-2024) & (USD Million)
    Table 121. South America Human Rabies Vaccine (Vero Cell) Consumption Value by Country (2025-2030) & (USD Million)
    Table 122. Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2019-2024) & (K Units)
    Table 123. Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Quantity by Type (2025-2030) & (K Units)
    Table 124. Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2019-2024) & (K Units)
    Table 125. Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Quantity by Application (2025-2030) & (K Units)
    Table 126. Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Quantity by Region (2019-2024) & (K Units)
    Table 127. Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Quantity by Region (2025-2030) & (K Units)
    Table 128. Middle East & Africa Human Rabies Vaccine (Vero Cell) Consumption Value by Region (2019-2024) & (USD Million)
    Table 129. Middle East & Africa Human Rabies Vaccine (Vero Cell) Consumption Value by Region (2025-2030) & (USD Million)
    Table 130. Human Rabies Vaccine (Vero Cell) Raw Material
    Table 131. Key Manufacturers of Human Rabies Vaccine (Vero Cell) Raw Materials
    Table 132. Human Rabies Vaccine (Vero Cell) Typical Distributors
    Table 133. Human Rabies Vaccine (Vero Cell) Typical Customers
List of Figures
    Figure 1. Human Rabies Vaccine (Vero Cell) Picture
    Figure 2. Global Human Rabies Vaccine (Vero Cell) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Human Rabies Vaccine (Vero Cell) Consumption Value Market Share by Type in 2023
    Figure 4. 0.5ml Examples
    Figure 5. 1ml Examples
    Figure 6. Global Human Rabies Vaccine (Vero Cell) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 7. Global Human Rabies Vaccine (Vero Cell) Consumption Value Market Share by Application in 2023
    Figure 8. Hospital Examples
    Figure 9. Clinic Examples
    Figure 10. Global Human Rabies Vaccine (Vero Cell) Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 11. Global Human Rabies Vaccine (Vero Cell) Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 12. Global Human Rabies Vaccine (Vero Cell) Sales Quantity (2019-2030) & (K Units)
    Figure 13. Global Human Rabies Vaccine (Vero Cell) Average Price (2019-2030) & (US$/Unit)
    Figure 14. Global Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Manufacturer in 2023
    Figure 15. Global Human Rabies Vaccine (Vero Cell) Consumption Value Market Share by Manufacturer in 2023
    Figure 16. Producer Shipments of Human Rabies Vaccine (Vero Cell) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 17. Top 3 Human Rabies Vaccine (Vero Cell) Manufacturer (Consumption Value) Market Share in 2023
    Figure 18. Top 6 Human Rabies Vaccine (Vero Cell) Manufacturer (Consumption Value) Market Share in 2023
    Figure 19. Global Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Region (2019-2030)
    Figure 20. Global Human Rabies Vaccine (Vero Cell) Consumption Value Market Share by Region (2019-2030)
    Figure 21. North America Human Rabies Vaccine (Vero Cell) Consumption Value (2019-2030) & (USD Million)
    Figure 22. Europe Human Rabies Vaccine (Vero Cell) Consumption Value (2019-2030) & (USD Million)
    Figure 23. Asia-Pacific Human Rabies Vaccine (Vero Cell) Consumption Value (2019-2030) & (USD Million)
    Figure 24. South America Human Rabies Vaccine (Vero Cell) Consumption Value (2019-2030) & (USD Million)
    Figure 25. Middle East & Africa Human Rabies Vaccine (Vero Cell) Consumption Value (2019-2030) & (USD Million)
    Figure 26. Global Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Type (2019-2030)
    Figure 27. Global Human Rabies Vaccine (Vero Cell) Consumption Value Market Share by Type (2019-2030)
    Figure 28. Global Human Rabies Vaccine (Vero Cell) Average Price by Type (2019-2030) & (US$/Unit)
    Figure 29. Global Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Application (2019-2030)
    Figure 30. Global Human Rabies Vaccine (Vero Cell) Consumption Value Market Share by Application (2019-2030)
    Figure 31. Global Human Rabies Vaccine (Vero Cell) Average Price by Application (2019-2030) & (US$/Unit)
    Figure 32. North America Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Type (2019-2030)
    Figure 33. North America Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Application (2019-2030)
    Figure 34. North America Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Country (2019-2030)
    Figure 35. North America Human Rabies Vaccine (Vero Cell) Consumption Value Market Share by Country (2019-2030)
    Figure 36. United States Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 37. Canada Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 38. Mexico Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 39. Europe Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Type (2019-2030)
    Figure 40. Europe Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Application (2019-2030)
    Figure 41. Europe Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Country (2019-2030)
    Figure 42. Europe Human Rabies Vaccine (Vero Cell) Consumption Value Market Share by Country (2019-2030)
    Figure 43. Germany Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 44. France Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 45. United Kingdom Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 46. Russia Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. Italy Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. Asia-Pacific Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Type (2019-2030)
    Figure 49. Asia-Pacific Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Application (2019-2030)
    Figure 50. Asia-Pacific Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Region (2019-2030)
    Figure 51. Asia-Pacific Human Rabies Vaccine (Vero Cell) Consumption Value Market Share by Region (2019-2030)
    Figure 52. China Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 53. Japan Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 54. Korea Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 55. India Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. Southeast Asia Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Australia Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. South America Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Type (2019-2030)
    Figure 59. South America Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Application (2019-2030)
    Figure 60. South America Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Country (2019-2030)
    Figure 61. South America Human Rabies Vaccine (Vero Cell) Consumption Value Market Share by Country (2019-2030)
    Figure 62. Brazil Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 63. Argentina Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 64. Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Type (2019-2030)
    Figure 65. Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Application (2019-2030)
    Figure 66. Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share by Region (2019-2030)
    Figure 67. Middle East & Africa Human Rabies Vaccine (Vero Cell) Consumption Value Market Share by Region (2019-2030)
    Figure 68. Turkey Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 69. Egypt Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 70. Saudi Arabia Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 71. South Africa Human Rabies Vaccine (Vero Cell) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. Human Rabies Vaccine (Vero Cell) Market Drivers
    Figure 73. Human Rabies Vaccine (Vero Cell) Market Restraints
    Figure 74. Human Rabies Vaccine (Vero Cell) Market Trends
    Figure 75. Porters Five Forces Analysis
    Figure 76. Manufacturing Cost Structure Analysis of Human Rabies Vaccine (Vero Cell) in 2023
    Figure 77. Manufacturing Process Analysis of Human Rabies Vaccine (Vero Cell)
    Figure 78. Human Rabies Vaccine (Vero Cell) Industrial Chain
    Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 80. Direct Channel Pros & Cons
    Figure 81. Indirect Channel Pros & Cons
    Figure 82. Methodology
    Figure 83. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Liaoning Chengda
Guangzhou Nuocheng
Ningbo Rong'an
Hualan Bio-vaccine
Sanofi Pasteur SA
Bharat Biotech
Bavarian Nordic
Serum Institute of India Pvt.
Chengdu Kanghua Biology
Changchun Zhuoyi Biology
Dalian Yali Peak
Jilin Huikang Biopharmaceutical Co., Ltd.

Related Reports

Global Human Rabies Vaccine (Vero Cell) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Human Rabies Vaccine (Vero Cell) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 28 Apr 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Human Rabies Vaccine (Vero Cell) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Human Rabies Vaccine (Vero Cell) Supply, Demand and Key Producers, 2023-2029

Global Human Rabies Vaccine (Vero Cell) Supply, Demand and Key Producers, 2023-2029

date 28 Apr 2023

date Pharma & Healthcare

The global Human Rabies Vaccine (Vero Cell) market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Product Tags

Human Rabies Vaccine (Vero Cell)

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>